CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,785,271 | -15.9% | 238,261 | -3.3% | 0.01% | -16.7% |
| Q2 2023 | $3,312,409 | -58.2% | 246,459 | -48.5% | 0.01% | -60.0% |
| Q1 2023 | $7,930,297 | +35.5% | 478,305 | +52.0% | 0.02% | +25.0% |
| Q4 2022 | $5,853,941 | +52.1% | 314,728 | +4.9% | 0.01% | +33.3% |
| Q3 2022 | $3,849,000 | +132.3% | 300,013 | +26.9% | 0.01% | +125.0% |
| Q2 2022 | $1,657,000 | -15.8% | 236,339 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,968,000 | +22.4% | 237,401 | -0.1% | 0.00% | +33.3% |
| Q4 2021 | $1,608,000 | +27.0% | 237,581 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $1,266,000 | -7.9% | 238,949 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,374,000 | +25.8% | 238,949 | +0.8% | 0.00% | +50.0% |
| Q1 2021 | $1,092,000 | +38.1% | 236,951 | +0.0% | 0.00% | 0.0% |
| Q4 2020 | $791,000 | +12.4% | 236,911 | -0.0% | 0.00% | 0.0% |
| Q3 2020 | $704,000 | -37.6% | 236,936 | -3.0% | 0.00% | -50.0% |
| Q2 2020 | $1,129,000 | +23.8% | 244,324 | +3.1% | 0.00% | 0.0% |
| Q1 2020 | $912,000 | +2.7% | 236,901 | 0.0% | 0.00% | +33.3% |
| Q4 2019 | $888,000 | -29.4% | 236,901 | 0.0% | 0.00% | -40.0% |
| Q3 2019 | $1,258,000 | +37.9% | 236,901 | -0.3% | 0.01% | +25.0% |
| Q2 2019 | $912,000 | -24.5% | 237,536 | +0.3% | 0.00% | -20.0% |
| Q1 2019 | $1,208,000 | +165.5% | 236,901 | 0.0% | 0.01% | +150.0% |
| Q4 2018 | $455,000 | -49.2% | 236,901 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $895,000 | +21.1% | 236,901 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $739,000 | +30.6% | 236,901 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $566,000 | +1351.3% | 236,901 | +1428.4% | 0.00% | – |
| Q3 2017 | $39,000 | -9.3% | 15,500 | 0.0% | 0.00% | – |
| Q2 2017 | $43,000 | +43.3% | 15,500 | 0.0% | 0.00% | – |
| Q1 2017 | $30,000 | +87.5% | 15,500 | 0.0% | 0.00% | – |
| Q4 2016 | $16,000 | -5.9% | 15,500 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | +54.5% | 15,500 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | -31.2% | 15,500 | +10.7% | 0.00% | – |
| Q1 2016 | $16,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |